|
Red cell distribution width determination
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
RDW - Red blood cell distribution width result
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
Acute GVH disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
Recent data have suggested that a pleiotropic T-cell immunomodulatory protein (TIP) could effectively mediate inflammatory cytokines of mammalian immune response against acute graft-versus-host disease in animal models.
|
31104402 |
2019 |
|
Tumor Cell Invasion
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
ExPEC harboring a deletion of the gene encoding the mannose-binding type 1 pilus tip protein FimH demonstrated reduced binding and invasion compared to strains lacking known <i>E. coli</i> virulence factors.
|
28808163 |
2017 |
|
Tumor Cell Invasion
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
The interaction between RUVBL1 and ITFG1 is required for breast cancer cell collective invasion and progression.
|
28341484 |
2017 |
|
Acute GVH disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
Treatment of primary human and murine T cells with TIP in vitro resulted in the secretion of IFN-gamma, TNF-alpha, and IL-10, whereas in vivo TIP had a protective effect in a mouse acute graft-versus-host disease (GVHD) model.
|
12598909 |
2003 |
|
Otitis Media
|
0.010 |
Biomarker
|
disease |
BEFREE |
Grading TIP is a valid method for accurate diagnosis of pediatric otitis media and can predict the tympanometry result with high statistical significance.
|
31202036 |
2019 |
|
Teratoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that approximately half of the patient with cisplatin-refractory or relapsed GCT salvaged with TIP or TICE chemotherapy and evidence of residual disease are at risk of harboring either viable GCT or teratoma.
|
30296502 |
2019 |
|
Gastrointestinal Carcinoid Tumor
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that approximately half of the patient with cisplatin-refractory or relapsed GCT salvaged with TIP or TICE chemotherapy and evidence of residual disease are at risk of harboring either viable GCT or teratoma.
|
30296502 |
2019 |
|
Familial aplasia of the vermis
|
0.010 |
Biomarker
|
disease |
BEFREE |
We show that another Joubert syndrome-associated cilia tip protein, CSPP1, interacts with CEP104 at microtubules for the regulation of axoneme length.
|
31412255 |
2019 |
|
Nephrotoxic serum nephritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
The TNF-derived TIP peptide activates the epithelial sodium channel and ameliorates experimental nephrotoxic serum nephritis.
|
30905471 |
2019 |
|
Adult Teratoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that approximately half of the patient with cisplatin-refractory or relapsed GCT salvaged with TIP or TICE chemotherapy and evidence of residual disease are at risk of harboring either viable GCT or teratoma.
|
30296502 |
2019 |
|
Childhood Teratoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that approximately half of the patient with cisplatin-refractory or relapsed GCT salvaged with TIP or TICE chemotherapy and evidence of residual disease are at risk of harboring either viable GCT or teratoma.
|
30296502 |
2019 |
|
Infectious Otitis Media
|
0.010 |
Biomarker
|
disease |
BEFREE |
Grading TIP is a valid method for accurate diagnosis of pediatric otitis media and can predict the tympanometry result with high statistical significance.
|
31202036 |
2019 |
|
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
We expect TIP to be useful in a large number of emerging cancer immunity studies and development of effective immunotherapy biomarkers.
|
30154154 |
2018 |
|
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The E3 Ubiquitin Ligase HectD1 Suppresses EMT and Metastasis by Targeting the +TIP ACF7 for Degradation.
|
29386124 |
2018 |
|
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
We developed a user-friendly one-stop shop web tool called TIP to comprehensively resolve tumor immunophenotype.
|
30154154 |
2018 |
|
Sore to touch
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The muscle TIP had superior values of subjective tenderness, juiciness, and slight off-flavor intensity when compared to all other muscles.The TIP and SUB were similar in WBSF.
|
28942340 |
2018 |
|
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
We expect TIP to be useful in a large number of emerging cancer immunity studies and development of effective immunotherapy biomarkers.
|
30154154 |
2018 |
|
Malignant neoplasm of breast
|
0.010 |
Biomarker
|
disease |
BEFREE |
The interaction between RUVBL1 and ITFG1 is required for breast cancer cell collective invasion and progression.
|
28341484 |
2017 |
|
Cystic Fibrosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Inhaled tobramycin, used to manage P. aeruginosa infection in CF patients, is available as powder (tobramycin inhalation powder, TIP) and solution (tobramycin inhalation solution, TIS).
|
28643178 |
2017 |
|
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The interaction between RUVBL1 and ITFG1 is required for breast cancer cell collective invasion and progression.
|
28341484 |
2017 |
|
Invasive carcinoma of breast
|
0.010 |
Biomarker
|
disease |
BEFREE |
Targeting collective invasion promoted by RUVBL1-ITFG1 complex provides a novel therapeutic strategy to improve the prognosis of invasive breast cancer.
|
28341484 |
2017 |
|
Parasitic Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
This study characterized the PfTip protein, a homolog of the human T‑cell immunomodulatory protein, and examined its function in preventing parasite infection.
|
26935027 |
2016 |
|
Mammary Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Microtubule plus‑end‑binding protein (+TIP) EB1 has been shown to be upregulated in breast cancer cells and promote breast tumor growth in vivo.
|
25310526 |
2015 |